SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-041718
Filing Date
2019-11-07
Accepted
2019-11-07 16:06:26
Documents
60
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q pti-10q_20190930.htm 10-Q 2371292
2 EX-10.31 pti-ex1031_26.htm EX-10.31 147767
3 EX-10.32 pti-ex1032_27.htm EX-10.32 77622
4 EX-31.1 pti-ex311_8.htm EX-31.1 12060
5 EX-31.2 pti-ex312_7.htm EX-31.2 11997
6 EX-32.1 pti-ex321_6.htm EX-32.1 13239
  Complete submission text file 0001564590-19-041718.txt   7076328

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT pti-20190930.xml EX-101.INS 1420127
8 XBRL TAXONOMY EXTENSION SCHEMA pti-20190930.xsd EX-101.SCH 37361
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pti-20190930_cal.xml EX-101.CAL 44412
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pti-20190930_def.xml EX-101.DEF 120196
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE pti-20190930_lab.xml EX-101.LAB 346073
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pti-20190930_pre.xml EX-101.PRE 250617
Mailing Address 80 GUEST STREET 5TH FLOOR BOSTON MA 02135
Business Address 80 GUEST STREET 5TH FLOOR BOSTON MA 02135 617-225-0096
PROTEOSTASIS THERAPEUTICS, INC. (Filer) CIK: 0001445283 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: 10-Q | Act: 34 | File No.: 001-37695 | Film No.: 191200303
SIC: 2834 Pharmaceutical Preparations